Clinical Trial Update: Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial [Phase 1, Phase 2]

View source ↗

Summary

The CLEAR Stroke trial tested a combination of eptifibatide and rt-PA for acute ischemic stroke and has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Activase (alteplase)
• Integrilin (Eptifibatide)

Snippet

Sponsor: University of Cincinnati | Conditions: Stroke | Phase 1, Phase 2 | Status: COMPLETED